6zgx
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 6zgx is ON HOLD Authors: Mackinnon, S.R., Bezerra, G.A., Zhang, M., Foster, W., Krojer, T., Brandao-Neto, J., Douangamath, A., Arrowsmith, C., Edwar...) |
|||
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide== | |
| + | <StructureSection load='6zgx' size='340' side='right'caption='[[6zgx]], [[Resolution|resolution]] 1.86Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ZGX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6ZGX FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.86Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GAL:BETA-D-GALACTOSE'>GAL</scene>, <scene name='pdbligand=HFK:2-(1,3-benzoxazol-2-ylamino)spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclohexane]-5-one'>HFK</scene>, <scene name='pdbligand=S6V:1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea'>S6V</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6zgx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zgx OCA], [https://pdbe.org/6zgx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6zgx RCSB], [https://www.ebi.ac.uk/pdbsum/6zgx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6zgx ProSAT]</span></td></tr> | ||
| + | </table> | ||
| - | + | ==See Also== | |
| - | + | *[[Galactokinase|Galactokinase]] | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Arrowsmith C]] |
| - | [[Category: | + | [[Category: Bezerra GA]] |
| - | [[Category: | + | [[Category: Bountra C]] |
| - | [[Category: | + | [[Category: Brandao-Neto J]] |
| - | [[Category: | + | [[Category: Brennan P]] |
| - | [[Category: | + | [[Category: Douangamath A]] |
| - | [[Category: | + | [[Category: Edwards A]] |
| - | [[Category: | + | [[Category: Foster W]] |
| - | [[Category: | + | [[Category: Krojer T]] |
| - | [[Category: | + | [[Category: Lai K]] |
| - | [[Category: | + | [[Category: Mackinnon SR]] |
| - | [[Category: | + | [[Category: Yue WW]] |
| + | [[Category: Zhang M]] | ||
Current revision
Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide
| |||||||||||
Categories: Large Structures | Arrowsmith C | Bezerra GA | Bountra C | Brandao-Neto J | Brennan P | Douangamath A | Edwards A | Foster W | Krojer T | Lai K | Mackinnon SR | Yue WW | Zhang M
